✦ LIBER ✦

Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer

✍ Scribed by Luciane R. Cavalli; Rebecca B. Riggins; Antai Wang; Robert Clarke; Bassem R. Haddad

Book ID: 106378373
Publisher: Springer US
Year: 2009
Tongue: English
Weight: 189 KB
Volume: 121
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-009-0509-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Frequent allelic loss at the TOC locus o

Frequent allelic loss at the TOC locus on 17q25.1 in primary breast cancers

✍ Koichi Fukino; Aritoshi Iida; Akira Teramoto; Goi Sakamoto; Fujio Kasumi; Yusuke 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

Sporadic breast cancers often show allelic losses on the long arm of chromosome 17. Since the BRCA1 gene lies at 17q21.1 and the TOC locus, associated with esophageal cancer, lies at 17q25.1, either gene could be the target of those losses. We examined both loci in 178 primary breast cancers, using

Frequent loss of heterozygosity at the D

Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer

✍ Benachenhou, N; Guiral, S; Gorska-Flipot, I; Labuda, D; Sinnett, D 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 148 KB

Loss of heterozygosity at 13q14 correlat

Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer

✍ Ivan Bièche; Rosette Lidereau 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

Hypermethylation of the tumor suppressor

Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers

✍ Mei Y. Yu; Joanna H.M. Tong; Paul K.S. Chan; Tin L. Lee; Michael W.Y. Chan; Anth 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 162 KB 👁 1 views

## Abstract Loss of heterozygosity (LOH) at chromosome 3p21 is frequent in cervical cancers. The candidate tumor suppressor gene, __RASSF1A__ located at 3p21.3, is found to be inactivated in several major human cancers, implicating its significance in carcinogenesis. We aimed to investigate the sta

Loss of heterozygosity at the TP53 gene:

Loss of heterozygosity at the TP53 gene: Independent occurrence from genetic instability events in node-negative breast cancer

✍ Sarab Lizard-Nacol; Jean-Marc Riedinger; Gérard Lizard; Anne-Lise Glasser; Nolwe 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 2 views

TP53 abnormalities have been reported as an early event in the process of cellular transformation of human breast cancers, and involved in mammary-tumor evolution, from in situ to invasive disease. In this study, node-negative (N-) tumors were examined for TP53 allelic loss in relation to different

Allele-specific loss of heterozygosity a

Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation

✍ Kanokwan Kittiniyom; Michelle Mastronardi; Martha Roemer; Wendy A. Wells; E. Rob 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 764 KB

## Abstract DAL‐1/4.1B (__EPB41L3__)is a member of the protein 4.1 superfamily, which encompasses structural proteins that play important roles in membrane processes via interactions with actin, spectrin, and the cytoplasmic domains of integral membrane proteins. __DAL‐1/4.1B__ localizes within chr